Published in Journal of Neuroinflammation · View the paper (DOI)
Researchers at U of A have identified a potential target for treating multiple sclerosis by discovering an underlying defect in brain cells. The study found that two sub-components within a cell are miscommunicating in patients with MS, triggering dysfunction and toxicity for brain cells.
Coverage from 2 institutions